Easing Doubts

The US National Institutes of Health caused many researchers to become concerned when it announced in 2010 that the Clinical and Translational Science Awards program would be under the auspices of the then-proposed, now-realized National Center for Advancing Translational Sciences, says ScienceInsider's Jocelyn Kaiser. The worry for researchers was that NCATS officials would have no interest in supporting CTSAs for aspects of medicine that don't involve therapeutics, she adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.